European Journal of Medicinal Chemistry · 2018 · 21 citations · 31 references
MedicineMedicinal ChemistryOncologyChemotherapyDrug DiscoveryMolecular OncologyCancer Cell SignalingOncogene ActivationOncogene MutationsOncogenic ProliferationOncogenic Signaling PathwaysActivating MutationsCancer Cell Proliferation InhibitionCell Proliferation Inhibition AssaysFlt3 Gene RearrangementFlt3 InhibitionFlt3 Inhibitors
31
The Amber biomolecular simulation programs
David A. Case, Thomas E. Cheatham, Tom Darden et al. · Journal of Computational Chemistry · 2005 · 9.6K citations · Full text
Tingjun Hou, Junmei Wang, Youyong Li et al. · Journal of Chemical Information and Modeling · 2010 · 2.8K citations
A small molecule–kinase interaction map for clinical kinase inhibitors
Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch, Timothy J. Ley, Daniel C. Link et al. · Cell · 2012 · 1.6K citations · Full text
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Catherine C. Smith, Qi Wang, Chen-Shan Chin et al. · Nature · 2012 · 745 citations
Medicine, Genetics, Hematology +13